HESKA CORPORATION (NASDAQ:HSKA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
HESKA CORPORATION (NASDAQ:HSKA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On June 1, 2019, Heska Corporation (the “Company”) amended and restated its employment agreement (the \”Employment Agreement\”) with Ms. Catherine I. Grassman to reflect (i) her previously announced promotion to serve as the Company’s Executive Vice President, Chief Financial Officer, (ii) an immediate increase to her annual salary to $290,000, and (iii) an increase in the severance amount payable to twelve months\’ base salary from six months\’ base salary for a termination by the Company without Cause or by Ms. Grassman for Good Reason (as each of such terms are defined in the Employment Agreement) on or before June 1, 2022, among other minor and conforming changes. The foregoing is a summary only and qualified in its entirety to the full text of the Employment Agreement, a copy of which is filed as exhibit 99.1 hereto and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
>(d) Exhibits.
HESKA CORP Exhibit
EX-99.1 2 exhibit991grassmanemployee.htm EXHIBIT 99.1 Exhibit Exhibit 99.1EMPLOYMENT AGREEMENTThis Employment Agreement (the “Agreement”) is made effective on June 1st,…
To view the full exhibit click
EX-99.1 2 exhibit991grassmanemployee.htm EXHIBIT 99.1 Exhibit Exhibit 99.1EMPLOYMENT AGREEMENTThis Employment Agreement (the “Agreement”) is made effective on June 1st,…
To view the full exhibit click
hereAbout HESKA CORPORATION (NASDAQ:HSKA)
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.
